126 related articles for article (PubMed ID: 16877878)
1. Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein.
Siess W
Pathophysiol Haemost Thromb; 2006; 35(3-4):292-304. PubMed ID: 16877878
[TBL] [Abstract][Full Text] [Related]
2. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.
Siess W; Zangl KJ; Essler M; Bauer M; Brandl R; Corrinth C; Bittman R; Tigyi G; Aepfelbacher M
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6931-6. PubMed ID: 10359816
[TBL] [Abstract][Full Text] [Related]
4. Thrombogenic and atherogenic activities of lysophosphatidic acid.
Siess W; Tigyi G
J Cell Biochem; 2004 Aug; 92(6):1086-94. PubMed ID: 15258894
[TBL] [Abstract][Full Text] [Related]
5. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
Haserück N; Erl W; Pandey D; Tigyi G; Ohlmann P; Ravanat C; Gachet C; Siess W
Blood; 2004 Apr; 103(7):2585-92. PubMed ID: 14645014
[TBL] [Abstract][Full Text] [Related]
6. Modified low-density lipoproteins and high-density lipoproteins. From investigation tools to real in vivo players.
Koller E; Volf I; Gurvitz A; Koller F
Pathophysiol Haemost Thromb; 2006; 35(3-4):322-45. PubMed ID: 16877881
[TBL] [Abstract][Full Text] [Related]
7. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation.
Aviram M
Thromb Haemost; 1995 Jul; 74(1):560-4. PubMed ID: 8578524
[TBL] [Abstract][Full Text] [Related]
8. Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2.
Weidtmann A; Scheithe R; Hrboticky N; Pietsch A; Lorenz R; Siess W
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1131-8. PubMed ID: 7627706
[TBL] [Abstract][Full Text] [Related]
9. A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein.
Martens JS; Lougheed M; Gómez-Muñoz A; Steinbrecher UP
J Biol Chem; 1999 Apr; 274(16):10903-10. PubMed ID: 10196168
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation by low density lipoprotein and high density lipoprotein.
Korporaal SJ; Akkerman JW
Pathophysiol Haemost Thromb; 2006; 35(3-4):270-80. PubMed ID: 16877876
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein and its effect on human blood platelets.
Relou IA; Hackeng CM; Akkerman JW; Malle E
Cell Mol Life Sci; 2003 May; 60(5):961-71. PubMed ID: 12827283
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.
Koba S; Pakala R; Watanabe T; Katagiri T; Benedict CR
Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):329-35. PubMed ID: 11133169
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
[TBL] [Abstract][Full Text] [Related]
14. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A.
Korporaal SJ; Van Eck M; Adelmeijer J; Ijsseldijk M; Out R; Lisman T; Lenting PJ; Van Berkel TJ; Akkerman JW
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2476-83. PubMed ID: 17761940
[TBL] [Abstract][Full Text] [Related]
15. High-density lipoprotein as a modulator of platelet and coagulation responses.
van der Stoep M; Korporaal SJ; Van Eck M
Cardiovasc Res; 2014 Aug; 103(3):362-71. PubMed ID: 24891399
[TBL] [Abstract][Full Text] [Related]
16. The interaction of β
Sato A; Nakazawa K; Sugawara A; Yamazaki Y; Ebina K
Biochim Biophys Acta Proteins Proteom; 2018 Dec; 1866(12):1232-1241. PubMed ID: 30312773
[TBL] [Abstract][Full Text] [Related]
17. From low-density lipoprotein to platelet activation.
Akkerman JW
Int J Biochem Cell Biol; 2008; 40(11):2374-8. PubMed ID: 18468940
[TBL] [Abstract][Full Text] [Related]
18. Modified lipoproteins provide lipids that modulate dendritic cell immune function.
Perrin-Cocon L; Diaz O; André P; Lotteau V
Biochimie; 2013 Jan; 95(1):103-8. PubMed ID: 22959067
[TBL] [Abstract][Full Text] [Related]
19. Mildly oxidized HDL decrease agonist-induced platelet aggregation and release of pro-coagulant platelet extracellular vesicles.
Tafelmeier M; Fischer A; Orsó E; Konovalova T; Böttcher A; Liebisch G; Matysik S; Schmitz G
J Steroid Biochem Mol Biol; 2017 May; 169():176-188. PubMed ID: 27163393
[TBL] [Abstract][Full Text] [Related]
20. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
